CN103386117B - 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 - Google Patents

一种低杂质含量的卡泊芬净制剂及其制备方法和用途 Download PDF

Info

Publication number
CN103386117B
CN103386117B CN201310275417.4A CN201310275417A CN103386117B CN 103386117 B CN103386117 B CN 103386117B CN 201310275417 A CN201310275417 A CN 201310275417A CN 103386117 B CN103386117 B CN 103386117B
Authority
CN
China
Prior art keywords
formula
pharmaceutical composition
shelf temperature
caspofungin
protective agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310275417.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN103386117A (zh
Inventor
洪云海
薛颖
沙丽新
季晓铭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Techwell Biopharmaceutical Co Ltd
Original Assignee
Shanghai Techwell Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Techwell Biopharmaceutical Co Ltd filed Critical Shanghai Techwell Biopharmaceutical Co Ltd
Priority to CN201310275417.4A priority Critical patent/CN103386117B/zh
Publication of CN103386117A publication Critical patent/CN103386117A/zh
Application granted granted Critical
Publication of CN103386117B publication Critical patent/CN103386117B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201310275417.4A 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 Expired - Fee Related CN103386117B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310275417.4A CN103386117B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201110288782X 2011-09-26
CN201110288782 2011-09-26
CN201110288782.X 2011-09-26
CN201310275417.4A CN103386117B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN201110434022.5A CN102488889B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201110434022.5A Division CN102488889B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Publications (2)

Publication Number Publication Date
CN103386117A CN103386117A (zh) 2013-11-13
CN103386117B true CN103386117B (zh) 2015-09-30

Family

ID=46180781

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201310275417.4A Expired - Fee Related CN103386117B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN201110434022.5A Active CN102488889B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201110434022.5A Active CN102488889B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Country Status (7)

Country Link
US (1) US9149502B2 (cg-RX-API-DMAC7.html)
KR (1) KR101660603B1 (cg-RX-API-DMAC7.html)
CN (2) CN103386117B (cg-RX-API-DMAC7.html)
DE (1) DE112012003996T5 (cg-RX-API-DMAC7.html)
ES (1) ES2519240B1 (cg-RX-API-DMAC7.html)
IN (1) IN2014KN00893A (cg-RX-API-DMAC7.html)
WO (1) WO2013044788A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103386117B (zh) * 2011-09-26 2015-09-30 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488886B (zh) 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212058A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲剂的组合物
CN103845725A (zh) * 2012-11-30 2014-06-11 上海医药工业研究院 一种更稳定的卡泊芬净组合物
JP2018503595A (ja) * 2014-09-24 2018-02-08 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその製剤
CN114236018B (zh) * 2022-02-24 2022-08-19 深圳市海滨制药有限公司 一种醋酸卡泊芬净及其异构体的检测方法
EP4364566A1 (en) * 2022-11-04 2024-05-08 B. Braun Melsungen AG Anti-fungal composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137197A1 (en) * 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
PE63998A1 (es) * 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
ATE294571T1 (de) * 1999-03-03 2005-05-15 Lilly Co Eli Echinocandin pharmazeutische zusammensetzungen
US6586574B1 (en) * 1999-08-17 2003-07-01 Nn A/S Stabilization of freeze-dried cake
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
EP2150537A4 (en) * 2007-06-01 2010-09-22 Acologix Inc STABLE PEPTIDE FORMULATION AT HIGH TEMPERATURE
US20090291996A1 (en) * 2008-05-21 2009-11-26 Ferenc Korodi Caspofungin free of caspofungin Co
US20100256074A1 (en) * 2008-06-25 2010-10-07 Chaim Eidelman Processes for preparing high purity aza cyclohexapeptides
US20090324635A1 (en) * 2008-06-25 2009-12-31 Ferenc Korodi Caspofungin free of caspofungin impurity A
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102153616A (zh) * 2010-12-27 2011-08-17 浙江海正药业股份有限公司 一种环己肽类化合物及其盐的分离纯化方法
CN103386117B (zh) * 2011-09-26 2015-09-30 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488886B (zh) * 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137197A1 (en) * 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
冻干保护剂及其保护机理的研究进展;杨洁等;《喀什师范学院学报》;20071130;第28卷(第6期);第47-48页 *

Also Published As

Publication number Publication date
CN102488889A (zh) 2012-06-13
KR20140069272A (ko) 2014-06-09
US20140221274A1 (en) 2014-08-07
CN102488889B (zh) 2014-01-22
KR101660603B1 (ko) 2016-09-27
ES2519240B1 (es) 2015-08-19
ES2519240A2 (es) 2014-11-06
WO2013044788A1 (zh) 2013-04-04
ES2519240R1 (es) 2014-11-12
US9149502B2 (en) 2015-10-06
CN103386117A (zh) 2013-11-13
DE112012003996T5 (de) 2014-08-14
IN2014KN00893A (cg-RX-API-DMAC7.html) 2015-10-09

Similar Documents

Publication Publication Date Title
CN103315969B (zh) 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103442695B (zh) 肠胃外注射用肽药物的稳定制剂
CN103386117A (zh) 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
DK2618814T3 (en) Caspofunginsammensætning
CN105078906A (zh) 一种含尿激酶的药物冻干制剂及其制备方法
CN102614492B (zh) 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
CN102488887B (zh) 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途
CN102614493B (zh) 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物
CN100528234C (zh) 一种注射用乳糖酸阿奇霉素及其制备方法
CN101455648B (zh) 一种葛根素冻干制剂
CN102512659B (zh) 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
CN102488888B (zh) 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
CN101816636A (zh) 一种单硝酸异山梨酯的冻干粉针剂及其制备方法
US20140275122A1 (en) Voriconazole Formulations
EP3225235A1 (en) Stable peptide formulations for parenteral injection
CN121081404B (zh) 含有托伐普坦磷酸钠的药物组合物
CN101376022A (zh) 含聚乙二醇降纤酶的药物组合物
CN103417474A (zh) 含有二丁酰环磷腺苷钙的注射用组合物
CN105327355A (zh) 一种肠胃外注射用肽药物的稳定制剂及其制备方法
CN116077445A (zh) 一种含有丝裂霉素的药物组合物及其制备方法
HK1245089B (en) Stable peptide formulations for parenteral injection
HK1208351A1 (en) Method for producing a freeze-dried pharmaceutical composition containing mitomycin c
HK1191230B (en) Stable formulations for parenteral injection of peptide drugs
CN102151249A (zh) 一种长春氟宁的药用组合物
CN103142997A (zh) 含有抗真菌剂和琥珀酸盐缓冲液的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150930

Termination date: 20181221

CF01 Termination of patent right due to non-payment of annual fee